NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Sukus re

JRII ( just anecdotes),

Do you think these estimates are based on anecdotes?

DCVax-L Survivals at
3 years: 1/3 or 33%
4 years: 1/4 or 25%
5 years: 1/5 or 20%

SOC Survivals at
3 years: 15%
5 years: 5%

SPOT ON Sukus!

SELECTIVE parsing by JR!!

HERE BELOW is a PROFESSIONAL EXPERT's view versus NEEDLESS BANTER:

See Phd Immuno Oncologist John Hopkins' Dr. Carlo Rago mid May 2019 latest update with disclosures:

]Hbpainter Thursday, 05/23/19 08:53:30 AM
Re: None
Post #
228650
of 237800
Carlo Rago's updated paper

https://www.scribd.com/document/411229128/A-Dendritic-Cell-Cancer-Vaccine-Shines-Brighter-for-Glioblastoma-Patients

ALSO:

https://www.prnewswire.com/news-releases/bigger-capital-and-district-2-capital-issue-white-paper-in-support-of-dcvax-l-a-second-generation-autologous-dendritic-cell-vaccine-300750945.html

https://www.crunchbase.com/person/carlo-rago#section-overview

DIFFERENT STROKES FOR DIFFERENT FOLKS